Sign inJoin waitlistJoin the waitlist

AS

Andrew Seidman

Attending Physician · New York Presbyterian Hospital

Credentials: · · · ·

History

Memorial Sloan Kettering Cancer Center
2026–Present

Hematology and Medical Oncology
Memorial Sloan Kettering Cancer Center
1988–1991
Internal Medicine
Pennsylvania Hospital
1985–1988
HAHNEMANN UNIV SCH OF MED, PHILADELPHIA
1981–1985

Research

Cardiac dysfunction in the trastuzumab clinical trials experience
Journal of Clinical Oncology · 2002 · First of 9 authors · Corresponding · 1,169 citations
Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer
Journal of Clinical Oncology · 1996 · 1,163 citations
Phase I studies of anti-epidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin
Journal of Clinical Oncology · 2000 · 614 citations

CH
Clifford Hudis
57 papers
LN
Larry Norton
49 papers
TG
Teresa Gilewski
23 papers
GD
Gabriella D'Andrea
21 papers · 1 as a fellow
MF
Monica Fornier
19 papers · 5 as a fellow
NS
Nancy Sklarin
18 papers
VC
Violante Currie
18 papers
MM
Mary Moynahan
17 papers
JB
José Baselga
16 papers
CD
Chau Dang
15 papers
SM
Shanu Modi
15 papers · 3 as a fellow
MT
Maria Theodoulou
14 papers

Clinical trials

A Study of Tucatinib Given Before Surgery to People With HER2+ Cancers That Have Spread to the Brain
Principal investigator · Active not recruiting · Phase 2
Memorial Sloan Kettering Cancer Center
2023–2028
Intermittent High-Dose Lapatinib in Tandem With Capecitabine for HER2 Overexpressed/Amplified Metastatic Breast Cancer With Central Nervous System (CNS) Metastases
Principal investigator · Completed · Phase 1
Memorial Sloan Kettering Cancer Center
2016–2021
Whole Brain Radiotherapy (WBRT) With Sorafenib for Breast Cancer Brain Metastases (BCBM)
Principal investigator · Completed · Phase 1
Memorial Sloan Kettering Cancer Center
2012–2022
18F-FLT-PET Imaging of the Brain in Patients With Metastatic Breast Cancer to the Brain Treated With Whole Brain Radiation Therapy With or Without Sorafenib: Comparison With MR Imaging of the Brain
Principal investigator · Completed
Memorial Sloan Kettering Cancer Center
2012–2021